Karen Reeves
Corporate Officer/Principal chez LIGAND PHARMACEUTICALS INCORPORATED
Profil
Karen Reeves is currently the SVP-Clinical Strategy & Investments at Ligand Pharmaceuticals, Inc. and the President & Chief Medical Officer at AZTherapies, Inc. Previously, she served as an Independent Director at Kiromic Biopharma, Inc. in 2022.
She also held positions at Pfizer Inc. as the VP & Head-Global Clinical Submissions Quality, Medivation LLC (California) as the Senior Vice President-Clinical Development, and Astellas Pharma, Inc. as the VP & Head-Global Medical Science.
Dr. Reeves completed her undergraduate degree at Yale University and obtained her doctorate from the University of Vermont College of Medicine.
Postes actifs de Karen Reeves
| Sociétés | Poste | Début |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 20/02/2024 |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | President | 01/09/2017 |
Anciens postes connus de Karen Reeves
| Sociétés | Poste | Fin |
|---|---|---|
| KIROMIC BIOPHARMA, INC. | Director/Board Member | 06/12/2022 |
| MEDIVATION INC | Corporate Officer/Principal | 29/03/2010 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formation de Karen Reeves
| Yale University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
